ClotTriever® Thrombectomy System Use-Result Survey in Japan

NCT06871683 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-05-04

No results posted yet for this study

Summary

The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan.

This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.

Conditions

  • Deep Vein Thrombosis

Interventions

DEVICE

ClotTriever® Thrombectomy System

ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.

Sponsors & Collaborators

  • Vorpal Technologies

    collaborator UNKNOWN
  • Inari Medical

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-17
Primary Completion
2028-03-31
Completion
2028-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06871683 on ClinicalTrials.gov